-
1
-
-
0022456416
-
Determination of salicylazosulphapyridine, sulphapyridine and its metabolites in serum and urine
-
DOI 10.1016/0731-7085(86)80048-6
-
Ahnfelt NO, Modin R, Odell ML, Ohlson U. (1986). Determination of salicylazosulphapyridine, sulphapyridine and its metabolites in serum and urine. J Pharm Biomed Anal 4:261-269. (Pubitemid 16024583)
-
(1986)
Journal of Pharmaceutical and Biomedical Analysis
, vol.4
, Issue.2
, pp. 261-269
-
-
Ahnfelt, N.-O.1
Modin, R.2
Odell, M.-L.3
Ohlson, U.4
-
2
-
-
0020681194
-
Tissue and bacterial splitting of sulphasalazine
-
Azad Khan AK, Guthrie G, Johnston HH, Truelove SC, Williamson DH. (1983). Tissue and bacterial splitting of sulphasalazine. Clin Sci 64:349-354. (Pubitemid 13173025)
-
(1983)
Clinical Science
, vol.64
, Issue.3
, pp. 349-354
-
-
Azad Khan, A.K.1
Guthrie, G.2
Johnston, H.H.3
-
3
-
-
0018934670
-
Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis
-
Azad Khan AK, Truelove SC. (1980). Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis. Gut 21:706-710. (Pubitemid 10020945)
-
(1980)
Gut
, vol.21
, Issue.8
, pp. 706-710
-
-
Khan, A.K.A.1
Truelove, S.C.2
-
5
-
-
84960560186
-
Sulphasalazine, sulphapyridine or 5-aminosalicylic acid - Which is the active moiety in rheumatoid arthritis?
-
Bird HA. (1995). Sulphasalazine, sulphapyridine or 5-aminosalicylic acid-which is the active moiety in rheumatoid arthritis? Br J Rheumatol 34 Suppl 2:16-19. (Pubitemid 26013482)
-
(1995)
British Journal of Rheumatology
, vol.34
, Issue.SUPPL. 2
, pp. 16-19
-
-
Bird, H.A.1
-
6
-
-
33747384568
-
VSL#3 probiotic mixture: A review of its use in chronic inflammatory bowel diseases
-
DOI 10.2165/00003495-200666100-00006
-
Chapman TM, Plosker GL, Figgitt DP. (2006). VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs 66:1371-1387. (Pubitemid 44250756)
-
(2006)
Drugs
, vol.66
, Issue.10
, pp. 1371-1387
-
-
Chapman, T.M.1
Plosker, G.L.2
Figgitt, D.P.3
-
7
-
-
34249946316
-
N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulfasalazine in the treatment of inflammatory bowel disease
-
Chen M, Xia B, Chen B, Guo Q, Li J, Ye M, Hu Z. (2007). N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease. Can J Gastroenterol 21:155-158. (Pubitemid 47061612)
-
(2007)
Canadian Journal of Gastroenterology
, vol.21
, Issue.3
, pp. 155-158
-
-
Chen, M.1
Xia, B.2
Chen, B.3
Guo, Q.4
Li, J.5
Ye, M.6
Hu, Z.7
-
8
-
-
0024543907
-
A simple and rapid liquid chromatographic method for the determination of major metabolites of sulfasalazine in biological fluids
-
DOI 10.1002/jps.2600780313
-
Chungi VS, Rekhi GS, Shargel L. (1989). A simple and rapid liquid chromatographic method for the determination of major metabolites of sulfasalazine in biological fluids. J Pharm Sci 78:235-238. (Pubitemid 19079849)
-
(1989)
Journal of Pharmaceutical Sciences
, vol.78
, Issue.3
, pp. 235-238
-
-
Chungi, V.S.1
Rekhi, G.S.2
Shargel, L.3
-
9
-
-
0018289765
-
Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats
-
Das KM, Chowdhury JR, Zapp B, Fara JW. (1979). Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats. Gastroenterology 77:280-284. (Pubitemid 9250750)
-
(1979)
Gastroenterology
, vol.77
, Issue.2
, pp. 280-284
-
-
Das, K.M.1
Chowdhury, J.R.2
Zapp, B.3
Fara, J.W.4
-
10
-
-
0017151106
-
Clinical pharmacokinetics of sulphasalazine
-
Das KM, Dubin R. (1976). Clinical pharmacokinetics of sulphasalazine. Clin Pharmacokinet 1:406-425.
-
(1976)
Clin Pharmacokinet
, vol.1
, pp. 406-425
-
-
Das, K.M.1
Dubin, R.2
-
11
-
-
0015916139
-
Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype
-
Das KM, Eastwood MA, McManus JP, Sircus W. (1973). Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med 289:491-495.
-
(1973)
N Engl J Med
, vol.289
, pp. 491-495
-
-
Das, K.M.1
Eastwood, M.A.2
McManus, J.P.3
Sircus, W.4
-
12
-
-
39049130131
-
Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities
-
DOI 10.1038/sj.ejcn.1602706, PII 1602706
-
De Preter V, Raemen H, Cloetens L, Houben E, Rutgeerts P, Verbeke K. (2008). Effect of dietary intervention with different pre-and probiotics on intestinal bacterial enzyme activities. Eur J Clin Nutr 62:225-231. (Pubitemid 351234257)
-
(2008)
European Journal of Clinical Nutrition
, vol.62
, Issue.2
, pp. 225-231
-
-
De Preter, V.1
Raemen, H.2
Cloetens, L.3
Houben, E.4
Rutgeerts, P.5
Verbeke, K.6
-
14
-
-
0017716374
-
Alterations in fecal microflora enzymes related to diet, age, lactobacillus supplements, and dimethylhydrazine
-
Goldin B, Gorbach SL. (1977). Alterations in fecal microflora enzymes related to diet, age, Lactobacillus supplements, and dimethylhydrazine. Cancer 40:2421-2426. (Pubitemid 8237741)
-
(1977)
Cancer
, vol.40
, Issue.5 SUPPL.
, pp. 2421-2426
-
-
Goldin, B.1
Gorbach, S.L.2
-
15
-
-
40049089729
-
Clinical indications for probiotics: An overview
-
discussion S144
-
Goldin BR, Gorbach SL. (2008). Clinical indications for probiotics: an overview. Clin Infect Dis 46 Suppl 2:S96-100; discussion S144.
-
(2008)
Clin Infect Dis
, vol.46
, Issue.SUPPL. 2
-
-
Goldin, B.R.1
Gorbach, S.L.2
-
16
-
-
0141628734
-
The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: A placebo-controlled study on the onset and duration of effects
-
DOI 10.1046/j.1365-2036.2003.01708.x
-
Goossens D, Jonkers D, Russel M, Stobberingh E, Van Den Bogaard A, StockbrUgger R. (2003). The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment Pharmacol Ther 18:495-505. (Pubitemid 37152290)
-
(2003)
Alimentary Pharmacology and Therapeutics
, vol.18
, Issue.5
, pp. 495-505
-
-
Goossens, D.1
Jonkers, D.2
Russel, M.3
Stobberingh, E.4
Van Den Bogaard, A.5
Stockbrugger, R.6
-
17
-
-
0025057187
-
Metabolism of drugs and other xenobiotics in the gut lumen and wall
-
Ilett KF, Tee LB, Reeves PT, Minchin RF. (1990). Metabolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacol Ther 46:67-93. (Pubitemid 20067882)
-
(1990)
Pharmacology and Therapeutics
, vol.46
, Issue.1
, pp. 67-93
-
-
Ilett, K.F.1
Tee, L.B.G.2
Reeves, P.T.3
Minchin, R.F.4
-
18
-
-
77957874781
-
Probiotic therapy for the treatment of spondyloarthritis: A randomized controlled trial
-
Jenks K, Stebbings S, Burton J, Schultz M, Herbison P, Highton J. (2010). Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. J Rheumatol 37:2118-2125.
-
(2010)
J Rheumatol
, vol.37
, pp. 2118-2125
-
-
Jenks, K.1
Stebbings, S.2
Burton, J.3
Schultz, M.4
Herbison, P.5
Highton, J.6
-
19
-
-
0028670112
-
Effect of sulphasalazine on gastrointestinal microflora and on mucosal heat shock protein expression in patients with rheumatoid arthritis
-
Kanerud L, Scheynius A, Nord CE, Hafström I. (1994). Effect of sulphasalazine on gastrointestinal microflora and on mucosal heat shock protein expression in patients with rheumatoid arthritis. Br J Rheumatol 33:1039-1048. (Pubitemid 2163002)
-
(1994)
British Journal of Rheumatology
, vol.33
, Issue.11
, pp. 1039-1048
-
-
Kanerud, L.1
Scheynius, A.2
Nord, C.E.3
Hafstrom, I.4
-
20
-
-
34249950623
-
Effect of Lactobacillus casei on the absorption of nifedipine from rat small intestine
-
Kato R, Yuasa H, Inoue K, Iwao T, Tanaka K, Ooi K, Hayashi Y. (2007). Effect of Lactobacillus casei on the absorption of nifedipine from rat small intestine. Drug Metab Pharmacokinet 22:96-102.
-
(2007)
Drug Metab Pharmacokinet
, vol.22
, pp. 96-102
-
-
Kato, R.1
Yuasa, H.2
Inoue, K.3
Iwao, T.4
Tanaka, K.5
Ooi, K.6
Hayashi, Y.7
-
21
-
-
0021806456
-
Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid
-
Klotz U. (1985). Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinet 10:285-302. (Pubitemid 15005992)
-
(1985)
Clinical Pharmacokinetics
, vol.10
, Issue.4
, pp. 285-302
-
-
Klotz, U.1
-
22
-
-
82155165640
-
Detection and specific enumeration of multi-strain probiotics in the lumen contents and mucus layers of the rat intestine after oral administration
-
Lee HJ, Orlovich DA, Tagg JR, Fawcett JP. (2009). Detection and specific enumeration of multi-strain probiotics in the lumen contents and mucus layers of the rat intestine after oral administration. Probiotic & Antimicro Prot 1:113-120.
-
(2009)
Probiotic & Antimicro Prot
, vol.1
, pp. 113-120
-
-
Lee, H.J.1
Orlovich, D.A.2
Tagg, J.R.3
Fawcett, J.P.4
-
23
-
-
75649147873
-
The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: A preliminary study
-
Lee HJ, Waller RD, Stebbings S, Highton J, Orlovich DA, Schmierer D, Fawcett JP. (2010). The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study. Int J Rheum Dis 13:48-54.
-
(2010)
Int J Rheum Dis
, vol.13
, pp. 48-54
-
-
Lee, H.J.1
Waller, R.D.2
Stebbings, S.3
Highton, J.4
Orlovich, D.A.5
Schmierer, D.6
Fawcett, J.P.7
-
24
-
-
0033636283
-
Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers
-
Liang E, Proudfoot J, Yazdanian M. (2000). Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers. Pharm Res 17:1168-1174.
-
(2000)
Pharm Res
, vol.17
, pp. 1168-1174
-
-
Liang, E.1
Proudfoot, J.2
Yazdanian, M.3
-
25
-
-
0033541550
-
Probiotics and prebiotics: Can regulating the activities of intestinal bacteria benefit health?
-
Macfarlane GT, Cummings JH. (1999). Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ 318:999-1003. (Pubitemid 29189095)
-
(1999)
British Medical Journal
, vol.318
, Issue.7189
, pp. 999-1003
-
-
Macfarlane, G.T.1
Cummings, J.H.2
-
26
-
-
0034831139
-
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
-
Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C. (2001). Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580-591. (Pubitemid 32822573)
-
(2001)
Gastroenterology
, vol.121
, Issue.3
, pp. 580-591
-
-
Madsen, K.1
Cornish, A.2
Soper, P.3
McKaigney, C.4
Jijon, H.5
Yachimec, C.6
Doyle, J.7
Jewell, L.8
De Simone, C.9
-
27
-
-
84855806325
-
How patients view probiotics: Findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome
-
Mercer M, Brinich MA, Geller G, Harrison K, Highland J, James K, Marshall P, McCormick JB, Tilburt J, Achkar JP, Farrell RM, Sharp RR. (2012). How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome. J Clin Gastroenterol 46:138-144.
-
(2012)
J Clin Gastroenterol
, vol.46
, pp. 138-144
-
-
Mercer, M.1
Brinich, M.A.2
Geller, G.3
Harrison, K.4
Highland, J.5
James, K.6
Marshall, P.7
McCormick, J.B.8
Tilburt, J.9
Achkar, J.P.10
Farrell, R.M.11
Sharp, R.R.12
-
28
-
-
75649111856
-
The influence of probiotic treatment on sulfasalazine metabolism in rat gut contents
-
Mikov M, Lee HJ, Fawcett JP. (2006). The influence of probiotic treatment on sulfasalazine metabolism in rat gut contents. Asian J Pharmacokinet Pharmacodynam 6:337-342.
-
(2006)
Asian J Pharmacokinet Pharmacodynam
, vol.6
, pp. 337-342
-
-
Mikov, M.1
Lee, H.J.2
Fawcett, J.P.3
-
29
-
-
40949166276
-
Gut microflora: A new target for therapeutic approaches in inflammatory bowel disease
-
DOI 10.1517/14728222.12.3.301
-
Mitsuyama K, Sata M. (2008). Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. Expert Opin Ther Targets 12:301-312. (Pubitemid 351419424)
-
(2008)
Expert Opinion on Therapeutic Targets
, vol.12
, Issue.3
, pp. 301-312
-
-
Mitsuyama, K.1
Sata, M.2
-
30
-
-
67349281229
-
Effects of Lactobacillus acidophilus on gut microflora metabolic biomarkers in fed and fasted rats
-
Mountzouris KC, Kotzampassi K, Tsirtsikos P, Kapoutzis K, Fegeros K. (2009). Effects of Lactobacillus acidophilus on gut microflora metabolic biomarkers in fed and fasted rats. Clin Nutr 28:318-324.
-
(2009)
Clin Nutr
, vol.28
, pp. 318-324
-
-
Mountzouris, K.C.1
Kotzampassi, K.2
Tsirtsikos, P.3
Kapoutzis, K.4
Fegeros, K.5
-
32
-
-
0035995860
-
Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly
-
DOI 10.1159/000063075
-
Ouwehand AC, Lagström H, Suomalainen T, Salminen S. (2002). Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab 46:159-162. (Pubitemid 34920700)
-
(2002)
Annals of Nutrition and Metabolism
, vol.46
, Issue.3-4
, pp. 159-162
-
-
Ouwehand, A.C.1
Lagstrom, H.2
Suomalainen, T.3
Salminen, S.4
-
33
-
-
0034763048
-
HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: Role of the mucus layer
-
DOI 10.1002/jps.1111
-
Pontier C, Pachot J, Botham R, Lenfant B, Arnaud P. (2001). HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. J Pharm Sci 90:1608-1619. (Pubitemid 32979755)
-
(2001)
Journal of Pharmaceutical Sciences
, vol.90
, Issue.10
, pp. 1608-1619
-
-
Pontier, C.1
Pachot, J.2
Botham, R.3
Lenfant, B.4
Arnaud, P.5
-
34
-
-
33746272565
-
Safe and efficacious probiotics: What are they?
-
DOI 10.1016/j.tim.2006.06.006, PII S0966842X0600151X
-
Reid G. (2006). Safe and efficacious probiotics: what are they? Trends Microbiol 14:348-352. (Pubitemid 44108653)
-
(2006)
Trends in Microbiology
, vol.14
, Issue.8
, pp. 348-352
-
-
Reid, G.1
-
35
-
-
0022589104
-
Enzyme activities of the hindgut microflora of laboratory animals and man
-
Rowland IR, Mallett AK, Bearne CA, Farthing MJ. (1986). Enzyme activities of the hindgut microflora of laboratory animals and man. Xenobiotica 16:519-523. (Pubitemid 16100763)
-
(1986)
Xenobiotica
, vol.16
, Issue.6
, pp. 519-523
-
-
Rowland, I.R.1
Mallett, A.K.2
Bearne, C.A.3
Farthing, M.J.G.4
-
36
-
-
0034469255
-
Bioanalytical method validation - A revisit with a decade of progress
-
DOI 10.1023/A:1007669411738
-
Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, McKay G, Miller KJ, Patnaik RN, Powell ML, Tonelli A, Viswanathan CT, Yacobi A. (2000). Bioanalytical method validation-a revisit with a decade of progress. Pharm Res 17:1551-1557. (Pubitemid 32217566)
-
(2000)
Pharmaceutical Research
, vol.17
, Issue.12
, pp. 1551-1557
-
-
Shah, V.P.1
Midha, K.K.2
Findlay, J.W.A.3
Hill, H.M.4
Hulse, J.D.5
McGilveray, I.J.6
McKay, G.7
Miller, K.J.8
Patnaik, R.N.9
Powell, M.L.10
Tonelli, A.11
Viswanathan, C.T.12
Yacobi, A.13
-
37
-
-
0034129592
-
Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20
-
DOI 10.1128/AEM.66.6.2578-2588.2000
-
Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J, Gopal PK. (2000). Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 66:2578-2588. (Pubitemid 30353968)
-
(2000)
Applied and Environmental Microbiology
, vol.66
, Issue.6
, pp. 2578-2588
-
-
Tannock, G.W.1
Munro, K.2
Harmsen, H.J.M.3
Welling, G.W.4
Smart, J.5
Gopal, P.K.6
-
38
-
-
5344231327
-
Monostrain, multistrain and multispecies probiotics - A comparison of functionality and efficacy
-
DOI 10.1016/j.ijfoodmicro.2004.05.012, PII S0168160504002855
-
Timmerman HM, Koning CJ, Mulder L, Rombouts FM, Beynen AC. (2004). Monostrain, multistrain and multispecies probiotics-A comparison of functionality and efficacy. Int J Food Microbiol 96:219-233. (Pubitemid 39349161)
-
(2004)
International Journal of Food Microbiology
, vol.96
, Issue.3
, pp. 219-233
-
-
Timmerman, H.M.1
Koning, C.J.M.2
Mulder, L.3
Rombouts, F.M.4
Beynen, A.C.5
-
39
-
-
9144236376
-
Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis
-
Tursi A, Brandimarte G, Giorgetti GM, Forti G, Modeo ME, Gigliobianco A. (2004). Low dose balsalazide plus high-potency probiotic preparation is more effective then balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit 10:PI126-131. (Pubitemid 39546045)
-
(2004)
Medical Science Monitor
, vol.10
, Issue.11
-
-
Tursi, A.1
Brandimarte, G.2
Giorgetti, G.M.3
Forti, G.4
Modeo, M.E.5
Gigliobianco, A.6
-
40
-
-
0034985984
-
Guidelines for adults on self-medication for the treatment of acute diarrhoea
-
DOI 10.1046/j.1365-2036.2001.00993.x
-
Wingate D, Phillips SF, Lewis SJ, Malagelada JR, Speelman P, Steffen R, Tytgat GN. (2001). Guidelines for adults on self-medication for the treatment of acute diarrhoea. Aliment Pharmacol Ther 15:773-782. (Pubitemid 32500423)
-
(2001)
Alimentary Pharmacology and Therapeutics
, vol.15
, Issue.6
, pp. 773-782
-
-
Wingate, D.1
Phillips, S.F.2
Lewis, S.J.3
Malagelada, J.-R.4
Speelman, P.5
Steffen, R.6
Tytgat, G.N.J.7
-
41
-
-
0020067917
-
Dietary fibre, bacterial metabolism and toxicity of nitrate in the rat
-
Wise A, Mallett AK, Rowland IR. (1982). Dietary fibre, bacterial metabolism and toxicity of nitrate in the rat. Xenobiotica 12:111-118. (Pubitemid 12158563)
-
(1982)
Xenobiotica
, vol.12
, Issue.2
, pp. 111-118
-
-
Wise, A.1
Mallett, A.K.2
Rowland, I.R.3
-
42
-
-
0028298968
-
Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid
-
Yamaguchi T, Sasaki K, Kurosaki Y, Nakayama T, Kimura T. (1994). Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid. J Drug Target 2:123-131. (Pubitemid 24194290)
-
(1994)
Journal of Drug Targeting
, vol.2
, Issue.2
, pp. 123-131
-
-
Yamaguchi, T.1
Sasaki, K.2
Kurosaki, Y.3
Nakayama, T.4
Kimura, T.5
-
43
-
-
0036300743
-
Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces
-
DOI 10.1128/AEM.68.7.3401-3407.2002
-
Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM. (2002). Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68:3401-3407. (Pubitemid 34734038)
-
(2002)
Applied and Environmental Microbiology
, vol.68
, Issue.7
, pp. 3401-3407
-
-
Zoetendal, E.G.1
Von Wright, A.2
Vilpponen-Salmela, T.3
Ben-Amor, K.4
Akkermans, A.D.L.5
De Vos, W.M.6
|